Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD5423 vs Budesonide in COPD
NCT01555099Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2012
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 8
01
Overview
A Phase 2 trial of AZD5423 in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Apr 2012; status: completed.
02
Drugs
AZD5423
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01555099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01555099.